This presentation deck was used in the October 2019 PM360 webinar sponsored by QxMD.
Description:
Generating top-of-mind awareness is a key challenge in diagnosing both rare and non-rare diseases that otherwise could be missed. Creating that awareness is one of the biggest challenges for pharmaceutical marketers.
Join this webcast to explore the modern disease state awareness campaign and how innovative platforms can help you bring your information closer to the point of care, all from the perspective of a practicing clinician.
If you are among the millions of men and women who stand before the mirror and see the equivalent of a spare tire around their midsections, you must be wondering whether there is anything you can do to get rid of it.
sociology of food and eating with details of psychology of food and eating, sociological perspectives history and background, food production and distribution, culture and civilization
Trendwatchers from around the world came together to identify the big shifts critical to pharmaceutical brands and healthcare marketers.
What's inside: 2016 will be the year an old debate reignites and simple digital tools fuel an incredible new era of clinical study. The patient journey will be rerouted and the tug of war at the point of care will get much more intense. Caregiving will approach a cliff, healthcare teams will get bigger, and patients will come to the exam room with new expectations. The science of motivation will face a crossroads and you’ll probably lose you Fitbit.
Lee Wales, VP Strategy Ashfield Healthcare Communications presented at Eyeforpharma 2017 on “The age of personalisation: adopting a customer-focused mindset to create more engaging and effective medical affairs programmes”.
Research on the best practices for healthcare social media. Presentation for #Newhouseprsm. Track with #hcsmbp. Interviewed @hjluks, @berci, @nicolaziady, @johnnostra
Digital communications bring opportunity and risk to the therapeutic relationship. Doctors and other health professionals can learn to collaborate in person and online to protect informed decision making. Modified slightly from a talk August 8 2019 at Brigham & Women's Hospital/Dana-Farber Cancer Institute.
Connectivity, Collaboration, and Disruption: Social Media and the OncologistRobert Miller
On 2/4/14, I presented a talk at Memorial Sloan-Kettering Cancer Center "Connectivity, Collaboration, and Disruption: Social Media and the Oncologist." I created a special hashtag - #msk_hcsm14 and used it to schedule a series of tweets to go out during the talk with some of my references.
Digital Health Revolution and the Opportunity for Dietitians to Lead Viable Synergy LLC
This is a presentation that was given at the 96th Annual Conference of the Ohio Academy of Nutrition and Dietetics conference on May 18, 2017. During the session we discussed the rise of digital health and its impact and role in health and healthcare delivery. Innovative software, hardware, and communication solutions were described and use cases discussed. Innovative programs and services being provided by dietitians in our region and around the world were highlighted.
Healthcare is undergoing a transformation. Consumers want to make informed choices and take control of their lives, and pharma companies must be ready to meet their needs. This means building a new healthcare ecosystem that places the patient at its center, with the “person” fully engaged in his or her own healthcare. But with this move to person-centric healthcare, payers and providers are no longer the main decision makers.
So what does this mean for today’s marketers?
In this exclusive Social On Us webinar we discuss:
- Where marketing is failing to address healthcare concerns
- How “big data” is a change-driver for a new healthcare ecosystem
- New opportunities for predictive and preventative medical intervention
- Impact of digital healthcare on patient privacy
Leveraging the power of social media in healthcare researchInSites on Stage
Leveraging the power of social media in healthcare research, presented by Robert Dossin at the MRS Healthcare Congress in London (UK) on Thursday March 6, 2013.
Understanding Physician/ Patient Conversations OnlineW2O Group
MDigitalLife's Managing Director & Founder, Greg Matthews led a webinar discussing the evolution of online interactions between patients and Healthcare Providers (HCPs) and what healthcare companies need to know to stay ahead of the curve.
If you are among the millions of men and women who stand before the mirror and see the equivalent of a spare tire around their midsections, you must be wondering whether there is anything you can do to get rid of it.
sociology of food and eating with details of psychology of food and eating, sociological perspectives history and background, food production and distribution, culture and civilization
Trendwatchers from around the world came together to identify the big shifts critical to pharmaceutical brands and healthcare marketers.
What's inside: 2016 will be the year an old debate reignites and simple digital tools fuel an incredible new era of clinical study. The patient journey will be rerouted and the tug of war at the point of care will get much more intense. Caregiving will approach a cliff, healthcare teams will get bigger, and patients will come to the exam room with new expectations. The science of motivation will face a crossroads and you’ll probably lose you Fitbit.
Lee Wales, VP Strategy Ashfield Healthcare Communications presented at Eyeforpharma 2017 on “The age of personalisation: adopting a customer-focused mindset to create more engaging and effective medical affairs programmes”.
Research on the best practices for healthcare social media. Presentation for #Newhouseprsm. Track with #hcsmbp. Interviewed @hjluks, @berci, @nicolaziady, @johnnostra
Digital communications bring opportunity and risk to the therapeutic relationship. Doctors and other health professionals can learn to collaborate in person and online to protect informed decision making. Modified slightly from a talk August 8 2019 at Brigham & Women's Hospital/Dana-Farber Cancer Institute.
Connectivity, Collaboration, and Disruption: Social Media and the OncologistRobert Miller
On 2/4/14, I presented a talk at Memorial Sloan-Kettering Cancer Center "Connectivity, Collaboration, and Disruption: Social Media and the Oncologist." I created a special hashtag - #msk_hcsm14 and used it to schedule a series of tweets to go out during the talk with some of my references.
Digital Health Revolution and the Opportunity for Dietitians to Lead Viable Synergy LLC
This is a presentation that was given at the 96th Annual Conference of the Ohio Academy of Nutrition and Dietetics conference on May 18, 2017. During the session we discussed the rise of digital health and its impact and role in health and healthcare delivery. Innovative software, hardware, and communication solutions were described and use cases discussed. Innovative programs and services being provided by dietitians in our region and around the world were highlighted.
Healthcare is undergoing a transformation. Consumers want to make informed choices and take control of their lives, and pharma companies must be ready to meet their needs. This means building a new healthcare ecosystem that places the patient at its center, with the “person” fully engaged in his or her own healthcare. But with this move to person-centric healthcare, payers and providers are no longer the main decision makers.
So what does this mean for today’s marketers?
In this exclusive Social On Us webinar we discuss:
- Where marketing is failing to address healthcare concerns
- How “big data” is a change-driver for a new healthcare ecosystem
- New opportunities for predictive and preventative medical intervention
- Impact of digital healthcare on patient privacy
Leveraging the power of social media in healthcare researchInSites on Stage
Leveraging the power of social media in healthcare research, presented by Robert Dossin at the MRS Healthcare Congress in London (UK) on Thursday March 6, 2013.
Understanding Physician/ Patient Conversations OnlineW2O Group
MDigitalLife's Managing Director & Founder, Greg Matthews led a webinar discussing the evolution of online interactions between patients and Healthcare Providers (HCPs) and what healthcare companies need to know to stay ahead of the curve.
Presentation: The Evolving Patient Journey
Presented by: Meredith Ressi, VP, Multichannel Marketing Solutions, Decision Resources Group
Healthcare communications today require an understanding of the complexity of patient decision making and how patients navigate the health system to get the care they need. What are the emerging trends in patient engagement, and how does channel reliance vary along the treatment continuum?
What Do Patients Really Want Out Of Adherence Technology?Inspire
Drawing insights from the 13,000-response Inspire Annual Survey, Dave Taylor, Inspire's director of research, presented at CBI’s Patient Adherence (PAAS) conference in Philadelphia, PA, in June 2015.
The epidemic of misinformation about vaccinesCILIP
Dr Pauline Paterson's (Research Fellow and co-director of The Vaccine Confidence Project, London School of Hygiene & Tropical Medicine) presentation at the CILIP 2017 Conference in Manchester #CILIPConf17
Whilst most people vaccinate, some groups or individuals delay or refuse vaccines due to concerns about safety, whether real or perceived, and concerns about information (including mis-information or mis-trust in information). Public concerns about vaccines have occurred around the world, spreading quickly and sometimes leading to vaccine refusals and disease outbreaks.
The presentation will explore case studies on non-vaccination of measles containing vaccine (MCV) and concerns around HPV vaccine globally. This talk will attempt to address the question of how misinformation can undermine public health, exploring selective exposure, selective perception and the issue of multiple realities.
Similar to Disease awareness campaign awareness pm360 3 (20)
ICH Guidelines for Pharmacovigilance.pdfNEHA GUPTA
The "ICH Guidelines for Pharmacovigilance" PDF provides a comprehensive overview of the International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use (ICH) guidelines related to pharmacovigilance. These guidelines aim to ensure that drugs are safe and effective for patients by monitoring and assessing adverse effects, ensuring proper reporting systems, and improving risk management practices. The document is essential for professionals in the pharmaceutical industry, regulatory authorities, and healthcare providers, offering detailed procedures and standards for pharmacovigilance activities to enhance drug safety and protect public health.
Defecation
Normal defecation begins with movement in the left colon, moving stool toward the anus. When stool reaches the rectum, the distention causes relaxation of the internal sphincter and an awareness of the need to defecate. At the time of defecation, the external sphincter relaxes, and abdominal muscles contract, increasing intrarectal pressure and forcing the stool out
The Valsalva maneuver exerts pressure to expel faeces through a voluntary contraction of the abdominal muscles while maintaining forced expiration against a closed airway. Patients with cardiovascular disease, glaucoma, increased intracranial pressure, or a new surgical wound are at greater risk for cardiac dysrhythmias and elevated blood pressure with the Valsalva maneuver and need to avoid straining to pass the stool.
Normal defecation is painless, resulting in passage of soft, formed stool
CONSTIPATION
Constipation is a symptom, not a disease. Improper diet, reduced fluid intake, lack of exercise, and certain medications can cause constipation. For example, patients receiving opiates for pain after surgery often require a stool softener or laxative to prevent constipation. The signs of constipation include infrequent bowel movements (less than every 3 days), difficulty passing stools, excessive straining, inability to defecate at will, and hard feaces
IMPACTION
Fecal impaction results from unrelieved constipation. It is a collection of hardened feces wedged in the rectum that a person cannot expel. In cases of severe impaction the mass extends up into the sigmoid colon.
DIARRHEA
Diarrhea is an increase in the number of stools and the passage of liquid, unformed feces. It is associated with disorders affecting digestion, absorption, and secretion in the GI tract. Intestinal contents pass through the small and large intestine too quickly to allow for the usual absorption of fluid and nutrients. Irritation within the colon results in increased mucus secretion. As a result, feces become watery, and the patient is unable to control the urge to defecate. Normally an anal bag is safe and effective in long-term treatment of patients with fecal incontinence at home, in hospice, or in the hospital. Fecal incontinence is expensive and a potentially dangerous condition in terms of contamination and risk of skin ulceration
HEMORRHOIDS
Hemorrhoids are dilated, engorged veins in the lining of the rectum. They are either external or internal.
FLATULENCE
As gas accumulates in the lumen of the intestines, the bowel wall stretches and distends (flatulence). It is a common cause of abdominal fullness, pain, and cramping. Normally intestinal gas escapes through the mouth (belching) or the anus (passing of flatus)
FECAL INCONTINENCE
Fecal incontinence is the inability to control passage of feces and gas from the anus. Incontinence harms a patient’s body image
PREPARATION AND GIVING OF LAXATIVESACCORDING TO POTTER AND PERRY,
An enema is the instillation of a solution into the rectum and sig
Deep Leg Vein Thrombosis (DVT): Meaning, Causes, Symptoms, Treatment, and Mor...The Lifesciences Magazine
Deep Leg Vein Thrombosis occurs when a blood clot forms in one or more of the deep veins in the legs. These clots can impede blood flow, leading to severe complications.
R3 Stem Cells and Kidney Repair A New Horizon in Nephrology.pptxR3 Stem Cell
R3 Stem Cells and Kidney Repair: A New Horizon in Nephrology" explores groundbreaking advancements in the use of R3 stem cells for kidney disease treatment. This insightful piece delves into the potential of these cells to regenerate damaged kidney tissue, offering new hope for patients and reshaping the future of nephrology.
Explore our infographic on 'Essential Metrics for Palliative Care Management' which highlights key performance indicators crucial for enhancing the quality and efficiency of palliative care services.
This visual guide breaks down important metrics across four categories: Patient-Centered Metrics, Care Efficiency Metrics, Quality of Life Metrics, and Staff Metrics. Each section is designed to help healthcare professionals monitor and improve care delivery for patients facing serious illnesses. Understand how to implement these metrics in your palliative care practices for better outcomes and higher satisfaction levels.
Empowering ACOs: Leveraging Quality Management Tools for MIPS and BeyondHealth Catalyst
Join us as we delve into the crucial realm of quality reporting for MSSP (Medicare Shared Savings Program) Accountable Care Organizations (ACOs).
In this session, we will explore how a robust quality management solution can empower your organization to meet regulatory requirements and improve processes for MIPS reporting and internal quality programs. Learn how our MeasureAble application enables compliance and fosters continuous improvement.
Global launch of the Healthy Ageing and Prevention Index 2nd wave – alongside...ILC- UK
The Healthy Ageing and Prevention Index is an online tool created by ILC that ranks countries on six metrics including, life span, health span, work span, income, environmental performance, and happiness. The Index helps us understand how well countries have adapted to longevity and inform decision makers on what must be done to maximise the economic benefits that comes with living well for longer.
Alongside the 77th World Health Assembly in Geneva on 28 May 2024, we launched the second version of our Index, allowing us to track progress and give new insights into what needs to be done to keep populations healthier for longer.
The speakers included:
Professor Orazio Schillaci, Minister of Health, Italy
Dr Hans Groth, Chairman of the Board, World Demographic & Ageing Forum
Professor Ilona Kickbusch, Founder and Chair, Global Health Centre, Geneva Graduate Institute and co-chair, World Health Summit Council
Dr Natasha Azzopardi Muscat, Director, Country Health Policies and Systems Division, World Health Organisation EURO
Dr Marta Lomazzi, Executive Manager, World Federation of Public Health Associations
Dr Shyam Bishen, Head, Centre for Health and Healthcare and Member of the Executive Committee, World Economic Forum
Dr Karin Tegmark Wisell, Director General, Public Health Agency of Sweden
One of the most developed cities of India, the city of Chennai is the capital of Tamilnadu and many people from different parts of India come here to earn their bread and butter. Being a metropolitan, the city is filled with towering building and beaches but the sad part as with almost every Indian city
The Importance of Community Nursing Care.pdfAD Healthcare
NDIS and Community 24/7 Nursing Care is a specific type of support that may be provided under the NDIS for individuals with complex medical needs who require ongoing nursing care in a community setting, such as their home or a supported accommodation facility.
CRISPR-Cas9, a revolutionary gene-editing tool, holds immense potential to reshape medicine, agriculture, and our understanding of life. But like any powerful tool, it comes with ethical considerations.
Unveiling CRISPR: This naturally occurring bacterial defense system (crRNA & Cas9 protein) fights viruses. Scientists repurposed it for precise gene editing (correction, deletion, insertion) by targeting specific DNA sequences.
The Promise: CRISPR offers exciting possibilities:
Gene Therapy: Correcting genetic diseases like cystic fibrosis.
Agriculture: Engineering crops resistant to pests and harsh environments.
Research: Studying gene function to unlock new knowledge.
The Peril: Ethical concerns demand attention:
Off-target Effects: Unintended DNA edits can have unforeseen consequences.
Eugenics: Misusing CRISPR for designer babies raises social and ethical questions.
Equity: High costs could limit access to this potentially life-saving technology.
The Path Forward: Responsible development is crucial:
International Collaboration: Clear guidelines are needed for research and human trials.
Public Education: Open discussions ensure informed decisions about CRISPR.
Prioritize Safety and Ethics: Safety and ethical principles must be paramount.
CRISPR offers a powerful tool for a better future, but responsible development and addressing ethical concerns are essential. By prioritizing safety, fostering open dialogue, and ensuring equitable access, we can harness CRISPR's power for the benefit of all. (2998 characters)
3. #DiseaseAwareness
Learning Objectives
1. Review why disease state awareness is important,
both for rare disease and more common disease
states
2. Identify surmountable challenges in disease
awareness
3. Learn 5 new tools to improve the success of your
next disease state awareness campaign
4. Incorporate innovative digital platforms in your
campaign strategy
7. #DiseaseAwareness
Rare Disease is Reasonably Common
Source: 1. Society to Improve Diagnosis in Medicine (2017) / 2. National Academy of Medicine (2015)
>30M
Americans have rare disease
1:2000
Definition of rare disease
8%
Of people have a rare disease
10. #DiseaseAwareness
Challenge with Rare – Patients Suffer from Conditions:
Most people haven’t heard of
Most doctors haven’t seen
Traditional therapies don’t treat
11. #DiseaseAwareness
Challenge & Opportunity
4.8 years
Time to rare disease diagnosis
<50%
Diagnosis Rates for Common Conditions. 1
20%
With Serious Illness
Misdiagnosed.
Source: Weaver J et al. Diagnosis and Treatment of Osteoporosis Before and After Fracture: A Side-by-Side Analysis of Commercially Insured and
Medicare Advantage Osteoporosis Patients.
J Manag Care Spec Pharm. 2017 Jul;23(7):735-744. doi: 10.18553/jmcp.2017.23.7.735.
16. #DiseaseAwareness
Where do we
engage?
And give clinicians what
they want… and need?
86%
HCPs use a
smartphone. 1
92%
HCPs view medical journals as
most important source for
continuing medical education. 2
Source: 1. Veeva 2016 Future of Medical Conferences / 2. Ashfield Meetings & Events 2016 Survey
23. #DiseaseAwareness
Decision support & research
dissemination designed to help UK
HCPs diagnose aHUS
Engaged >6100 target specialist MDs
Generated thousands of uses of
decision support tool & full-text
research views
Contributed to a 22% increase in
referrals to National Referral Centre
24. #DiseaseAwareness
Drive
engagement
with topic
reviews &
primary research
to put disease
state front of
mind
Inject credible content from the
peer-reviewed literature :
• Topic reviews to emphasize
disease state
• Case reports that highlight
how easy to miss
• Papers that show simplicity of
diagnosis
• Research that quantifies
impact of missed diagnosis
25. #DiseaseAwareness
Use digital CME
to raise awareness
&
close clinical
knowledge gaps
Explore emerging all-in-one HCP platforms
for content hosting & user acquisition.
AUDIO & MORE PLATFORMMOBILE & MICRO-FORMAT
Plus many others!
27. #DiseaseAwareness
Where to start?
1. Find disease awareness
platforms & partners
2. Collaborate with your
agencies & partners
to create tailored playbooks
Disease State
Awareness Branded
Pre launch Growth Maturity
“Diagnosis is extremely hard,” said Mark L. Graber, a senior fellow at the research institute RTI International and founder of the Society to Improve Diagnosis in Medicine. “There are 10,000 diseases and only 200 to 300 symptoms.”
20 percent of patients with serious conditions are first misdiagnosed
Graber was not involved in the Mayo Clinic research, which appears in the Journal of Evaluation in Clinical Practice.
[The government’s faltering attempt to hold a drug company accountable. ]
In 2015, the National Academy of Medicine reported that most people will receive an incorrect or late diagnosis at least once in their lives, sometimes with serious consequences. It cited one estimate that 12 million people — about 5 percent of adults who seek outpatient care — are misdiagnosed annually. The report also noted that diagnostic error is a relatively under-measured and understudied aspect of patient safety.
According to previous research cited in the new study, diagnostic errors “contribute to approximately 10 percent of patient deaths” and “account for 6 to 17 percent of adverse events in hospitals.” Graber estimates that the rate of misdiagnosis, although difficult to determine, occurs in 10 percent to 20 percent of cases.
perception the disease will never be seen, or futility in diagnosis as clinicians unaware of new treatment options.
A display ad is considered viewable when 50% of an ad’s pixels are in view on the screen for a minimum of one second as defined by the Media Rating Council
in 2018 Q1.
2014
Branded pharma sites have a closer to 60% bounce rate
Eg – fix the broken bone, not the osteoporosis
Tx the MI, not the lipids
In diabetes, Address HbA1C, not CV, renal or CHF risk
For non-rare diseases, keep top-of-mind awareness in GPs so they don’t miss harder to recognize cases / uncommon representations of disease state
2014
Branded pharma sites have a closer to 60% bounce rate
2014
Branded pharma sites have a closer to 60% bounce rate
Has to be authentic and educational
2014
Branded pharma sites have a closer to 60% bounce rate
Has to be authentic and educational
2014
Branded pharma sites have a closer to 60% bounce rate
Native ads are ads that appear as part of the design and flow of the web page they are located on. Rather than standing out as an obvious hard-selling ad, native ads tend to have an editorial look and feel, with a softer selling approach. Native ads commonly appear as sponsored posts in social media news feeds, as listings in search results on search engines such as Google or Bing, and as recommended content by content discovery platforms like Outbrain.
they also contribute to much higher ‘brand lift’ than display ads.
https://www.sharethrough.com/resources/native-ads-vs-display-ads/
Native ads are ads that appear as part of the design and flow of the web page they are located on. Rather than standing out as an obvious hard-selling ad, native ads tend to have an editorial look and feel, with a softer selling approach. Native ads commonly appear as sponsored posts in social media news feeds, as listings in search results on search engines such as Google or Bing, and as recommended content by content discovery platforms like Outbrain.
they also contribute to much higher ‘brand lift’ than display ads.
https://www.sharethrough.com/resources/native-ads-vs-display-ads/
HCPs are flooded with information, making knowledge acquisition & adoption difficult.
>16K new research papers per week
